Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women, through the ages of 18 and 55 years, inclusive.~Exclusion Criteria:~* Women who are pregnant, lactating, or of childbearing potential who are not using adequate contraceptive measures.~* Subjects who are displaying clinically significant homicidality or suicidality~* Clinically unstable medical disease, including cardiovascular, hepatic, renal, gastrointestinal, pulmonary, metabolic, endocrine or other systemic disease. Subjects should be biochemically euthyroid to enter the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Lisdexamfetamine (Type: ACTIVE_COMPARATOR): Drug
- Placebo (Type: PLACEBO_COMPARATOR): Drug

Based on this trial design, predict the completion outcome and termination type (if applicable).